Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002228:Carbenicillin / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005839:Gentamicins / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use*; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy*
D005839:Gentamicins; D010406:Penicillins; D002228:Carbenicillin